EksoNR is made by Ekso Bionics, based in Richmond, California, USA, founded in 2005.

Where is EksoNR deployed?

No verified deployments of EksoNR are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.

What is EksoNR's maturity stage?

EksoNR is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Robot model

EksoNR

Name: EksoNR
Brand: Ekso Bionics

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.

EksoNR is an exoskeleton robot built by Ekso Bionics.

Track EksoNREmail on verified state changes. Cap-flags flow through.

Machine-readable surfaces

Markdown mirror: /models/ekso-nr.md
JSON-LD: embedded in this page’s head
REST API: /v1/models/a4a2491a-bfdd-4ba3-b370-771d234bc136
Revision history: /models/ekso-nr/history
Data documentation: /data
Query this programmatically: Deploy MCP

Form factor: exoskeleton
Maturity stage: commercial
Lifecycle: active
Deployments: 0
ID: a4a2491a-bfdd-4ba3-b370-771d234bc136

Deploy Watch

Track EksoNR on Deploy.

We notify you when pricing, deployment status, or regulatory state changes against primary-source evidence, not when the maker issues claims.

Specs

use: medical rehab
control: weight-shift + user intent triggers powered steps
powered: yes (motor-driven)
regulatory: FDA cleared
body_region: lower-limb
availability: commercial

Manufacturer-attributed media (1)

Manufacturer-supplied media at the model level. Not tied to an independently verified named-site deployment. Verification posture is product-showcase from the maker, distinct from the deployment-verified evidence in the section above.

PRIMARY SOURCE

Courtesy of Ekso Bionics

Ekso Bionics footage of a stroke patient performing clinician-supervised assisted stepping in the EksoNR rehabilitation exoskeleton. The device provides adaptive assistance and the patient initiates each step (the robot does not walk the patient), so it is not autonomous. FDA-cleared for stroke and spinal-cord injury, later for acquired brain injury and multiple sclerosis; used in clinics, not sold for individual use.

Sources (2)

Common questions

What is EksoNR?: Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.
Who makes EksoNR?: EksoNR is made by Ekso Bionics, based in Richmond, California, USA, founded in 2005.
Where is EksoNR deployed?: No verified deployments of EksoNR are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
What is EksoNR's maturity stage?: EksoNR is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Methodology: Verified · 2 sources (no primary) · last reviewed 2026-06-06

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-06-06

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1: knowledge-base; Knowledge base
1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.